Marihuana Tax Act of 1937

Marihuana Tax Act of 1937
U.S. Government · Public domain · source
Name	Marihuana Tax Act of 1937
Enacted by	75th United States Congress
Effective date	August 2, 1937
Introduced by	Robert L. Doughton
Signed by	Franklin D. Roosevelt
Citations	50 Stat. 551

Marihuana Tax Act of 1937 The Marihuana Tax Act of 1937 was a United States federal law that imposed a taxing regime on cannabis transactions and functionally criminalized nonmedical marijuana possession and distribution. The Act was enacted during the administration of Franklin D. Roosevelt and reflected policy debates involving figures such as Harry J. Anslinger, institutions like the Federal Bureau of Narcotics, and interest conflicts among agricultural, pharmaceutical, and law enforcement stakeholders.

Background and Context

Debates leading to the Act drew on controversies involving cannabis cultivation disputes with proponents like Hemp for Victory advocates and opponents such as the United States Treasury Department’s Federal Bureau of Narcotics under Harry J. Anslinger and allied voices in the American Medical Association. Public campaigns intersected with media personalities including William Randolph Hearst and cultural productions such as the film Reefer Madness, while policy discussions referenced international agreements like the International Opium Convention and diplomatic pressures involving Mexico and the League of Nations. Industrial interests represented by advocates of Hemp and firms in the American Textile Manufacturers Institute met opposition from pharmaceutical companies and state-level actors including the California Department of Public Health, shaping perceptions of cannabis risks amid Prohibition-era regulatory frameworks connected to the Volstead Act and the broader trajectory of U.S. narcotics policy.

Legislative History and Passage

Drafting and promotion involved congressional figures such as Representative Robert L. Doughton and Senator Harry S. Truman in hearings before the United States House Committee on Ways and Means and the United States Senate Committee on Finance. Testimony and lobbying included representatives from the Federal Bureau of Narcotics, medical authorities from the American Medical Association, and agricultural stakeholders from groups like the National Industrial Hemp Association. The bill advanced through legislative procedures in the 75th United States Congress with floor debates influenced by public testimony, press coverage from outlets tied to William Randolph Hearst, and advocacy by temperance-aligned organizations that had engaged with the Anti-Saloon League. President Franklin D. Roosevelt signed the bill into law on August 2, 1937, completing a legislative process that reflected interbranch interactions among federal agencies, interest groups, and state authorities.

Provisions and Implementation

The Act imposed an excise tax requiring registration, transfer forms, and payment of a stamp or tax for growers, sellers, and purchasers of certain cannabis products, with enforcement mechanisms administered by the Internal Revenue Service and implemented in coordination with the Federal Bureau of Narcotics. It distinguished among hemp varieties used for fiber, medicines regulated by the Food and Drug Administration, and intoxicating preparations classified under the statute, creating administrative obligations for physicians, pharmacists, and agricultural producers including those associated with institutions such as Iowa State College and the United States Department of Agriculture. Compliance required documentation similar to that used under existing tax statutes administered by the United States Treasury Department, while state law enforcement agencies in jurisdictions like California, Texas, and New York applied local prosecutorial discretion in cases involving alleged noncompliance.

Legal Challenges and Court Rulings

Litigation soon challenged the statute’s constitutionality, with prominent cases reaching federal courts and ultimately the United States Supreme Court. Defendants and challengers included medical practitioners and distributors who contested the Act’s tax mechanism as a regulatory device evading the Commerce Clause and due process protections enshrined in precedents involving the Fourth Amendment and statutory interpretation by the Court. Key judicial review culminated in the Supreme Court decision in United States v. Doremus and later cases that scrutinized procedural burdens imposed by the tax framework; judicial scrutiny considered administrative law doctrines developed in earlier decisions such as NLRB v. Jones & Laughlin Steel Corp. and doctrinal developments concerning statutory penalties and evidentiary burdens.

Impact on Cannabis Policy and Society

The Act catalyzed a decade-spanning federal approach to cannabis that reshaped law enforcement priorities for agencies including the Federal Bureau of Narcotics and later the Drug Enforcement Administration, influenced medical research institutions such as Johns Hopkins University and pharmaceutical regulation by the Food and Drug Administration, and contributed to public perceptions molded by media outlets like Time (magazine) and cultural artifacts including Reefer Madness. It affected agricultural economies in regions where Hemp fiber had been produced, intersecting with initiatives by universities such as Cornell University and policy debates in state legislatures like those of Kentucky and Oregon. Social consequences included disparate enforcement outcomes in urban centers such as New York City, Los Angeles, and Chicago, and the statute played a formative role in the emergence of advocacy movements that later involved organizations like the National Organization for the Reform of Marijuana Laws and public policy scholars in institutions including Harvard Law School.

Repeal and Replacement (Controlled Substances Act)

By the late 1960s and early 1970s, shifting legal and scientific assessments by bodies such as the Commission on Marihuana and Drug Abuse (Shafer Commission) and executive review under presidents including Richard Nixon and Lyndon B. Johnson precipitated legislative reform culminating in the Controlled Substances Act of 1970 enacted by the 91st United States Congress and signed by President Richard Nixon. The Controlled Substances Act centralized federal drug regulation within schedules administered by the Drug Enforcement Administration and the Department of Justice, effectively superseding the tax-centric enforcement architecture established in 1937 and reshaping subsequent litigation in forums including the United States Court of Appeals and the United States Supreme Court.

Category:United States federal legislation Category:Cannabis law in the United States